Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Histone Deacetylase Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Histone Deacetylase Inhibitorsmarket, defines the market attractiveness level of Histone Deacetylase Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Histone Deacetylase Inhibitors industry, describes the types of Histone Deacetylase Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Histone Deacetylase Inhibitors market and the development prospects and opportunities of Histone Deacetylase Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Histone Deacetylase Inhibitors market in Chapter 13.
By Player:
Curis
Mirati Therapeutics
CrystalGenomics
Acetylon Pharmaceuticals
4SC AG
TetraLogic
MEI Pharma
Chroma Therapeutics
Onxeo
Celleron Therapeutics
Novartis
Repligen
By Type:
Competitive Inhibitors
Uncompetitive Inhibitors
Mixed Inhibitors
By End-User:
Psychiatry and Neurology
Cancer Treatment
Inflammatory Diseases
Other Diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Histone Deacetylase Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Histone Deacetylase Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Histone Deacetylase Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Histone Deacetylase Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Histone Deacetylase Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Histone Deacetylase Inhibitors Consumption (2017-2022)
-
7.2 United States Histone Deacetylase Inhibitors Consumption (2017-2022)
-
7.3 Europe Histone Deacetylase Inhibitors Consumption (2017-2022)
-
7.4 China Histone Deacetylase Inhibitors Consumption (2017-2022)
-
7.5 Japan Histone Deacetylase Inhibitors Consumption (2017-2022)
-
7.6 India Histone Deacetylase Inhibitors Consumption (2017-2022)
-
7.7 South Korea Histone Deacetylase Inhibitors Consumption (2017-2022)
8 Region and Country-wise Histone Deacetylase Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Histone Deacetylase Inhibitors Consumption Forecast (2022-2028)
9 Global Histone Deacetylase Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Histone Deacetylase Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Competitive Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Uncompetitive Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Mixed Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Histone Deacetylase Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Psychiatry and Neurology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Inflammatory Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Diseases Consumption and Growth Rate (2017-2022)
10 Global Histone Deacetylase Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Competitive Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Uncompetitive Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Mixed Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Psychiatry and Neurology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Inflammatory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global Histone Deacetylase Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Histone Deacetylase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Histone Deacetylase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Histone Deacetylase Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Histone Deacetylase Inhibitors Market Competitive Analysis
-
14.1 Curis
-
14.1.1 Curis Company Details
-
14.1.2 Curis Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Curis Histone Deacetylase Inhibitors Product and Service
-
14.2 Mirati Therapeutics
-
14.2.1 Mirati Therapeutics Company Details
-
14.2.2 Mirati Therapeutics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mirati Therapeutics Histone Deacetylase Inhibitors Product and Service
-
14.3 CrystalGenomics
-
14.3.1 CrystalGenomics Company Details
-
14.3.2 CrystalGenomics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CrystalGenomics Histone Deacetylase Inhibitors Product and Service
-
14.4 Acetylon Pharmaceuticals
-
14.4.1 Acetylon Pharmaceuticals Company Details
-
14.4.2 Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Product and Service
-
14.5 4SC AG
-
14.5.1 4SC AG Company Details
-
14.5.2 4SC AG Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 4SC AG Histone Deacetylase Inhibitors Product and Service
-
14.6 TetraLogic
-
14.6.1 TetraLogic Company Details
-
14.6.2 TetraLogic Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 TetraLogic Histone Deacetylase Inhibitors Product and Service
-
14.7 MEI Pharma
-
14.7.1 MEI Pharma Company Details
-
14.7.2 MEI Pharma Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 MEI Pharma Histone Deacetylase Inhibitors Product and Service
-
14.8 Chroma Therapeutics
-
14.8.1 Chroma Therapeutics Company Details
-
14.8.2 Chroma Therapeutics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Chroma Therapeutics Histone Deacetylase Inhibitors Product and Service
-
14.9 Onxeo
-
14.9.1 Onxeo Company Details
-
14.9.2 Onxeo Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Onxeo Histone Deacetylase Inhibitors Product and Service
-
14.10 Celleron Therapeutics
-
14.10.1 Celleron Therapeutics Company Details
-
14.10.2 Celleron Therapeutics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Celleron Therapeutics Histone Deacetylase Inhibitors Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis Histone Deacetylase Inhibitors Product and Service
-
14.12 Repligen
-
14.12.1 Repligen Company Details
-
14.12.2 Repligen Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Repligen Histone Deacetylase Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Histone Deacetylase Inhibitors
-
Figure Histone Deacetylase Inhibitors Picture
-
Table Global Histone Deacetylase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Histone Deacetylase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Histone Deacetylase Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Histone Deacetylase Inhibitors Consumption by Country (2017-2022)
-
Figure United States Histone Deacetylase Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Histone Deacetylase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Histone Deacetylase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Histone Deacetylase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Histone Deacetylase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Histone Deacetylase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Histone Deacetylase Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Histone Deacetylase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Competitive Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Uncompetitive Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Mixed Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Psychiatry and Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Competitive Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Uncompetitive Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mixed Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psychiatry and Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Histone Deacetylase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Histone Deacetylase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Curis (Foundation Year, Company Profile and etc.)
-
Table Curis Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curis Histone Deacetylase Inhibitors Product and Service
-
Table Mirati Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Mirati Therapeutics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mirati Therapeutics Histone Deacetylase Inhibitors Product and Service
-
Table CrystalGenomics (Foundation Year, Company Profile and etc.)
-
Table CrystalGenomics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table CrystalGenomics Histone Deacetylase Inhibitors Product and Service
-
Table Acetylon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Product and Service
-
Table 4SC AG (Foundation Year, Company Profile and etc.)
-
Table 4SC AG Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table 4SC AG Histone Deacetylase Inhibitors Product and Service
-
Table TetraLogic (Foundation Year, Company Profile and etc.)
-
Table TetraLogic Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table TetraLogic Histone Deacetylase Inhibitors Product and Service
-
Table MEI Pharma (Foundation Year, Company Profile and etc.)
-
Table MEI Pharma Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table MEI Pharma Histone Deacetylase Inhibitors Product and Service
-
Table Chroma Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Chroma Therapeutics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chroma Therapeutics Histone Deacetylase Inhibitors Product and Service
-
Table Onxeo (Foundation Year, Company Profile and etc.)
-
Table Onxeo Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onxeo Histone Deacetylase Inhibitors Product and Service
-
Table Celleron Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Celleron Therapeutics Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celleron Therapeutics Histone Deacetylase Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Histone Deacetylase Inhibitors Product and Service
-
Table Repligen (Foundation Year, Company Profile and etc.)
-
Table Repligen Histone Deacetylase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Repligen Histone Deacetylase Inhibitors Product and Service
-
